Background Congestion is a marker of adverse prognosis in patients with heart failure (HF).
In addition to brain natriuretic peptide (BNP), estimated plasma volume status (ePVS) …

Objective Congestion in acute heart failure (AHF) affects survival curves and hospital length
of stay (LOS). The evaluation of congestion, however, is not totally objective. The aim of this …

Assessing congestion is challenging but important to patients with chronic heart failure
(CHF). However, there are limited data regarding the association between estimated plasma …

The impact of sex on the assessment of congestion in acute heart failure (AHF) is still a
matter of debate. The objective of this analysis was to evaluate sex differences in the …

Background: Congestion is one of the main predictors of poor outcome in patients with heart
failure (HF); thus, a simple tool to evaluate plasma volume (PV), which can be used for risk …

Aims Even if treatment controls symptoms, patients with heart failure may still be congested.
We aimed at assessing the prevalence and clinical relevance of congestion in outpatients …

The aim of this study was to evaluate the relationship between anaemia and biomarkers of
central/peripheral congestion in heart failure (HF) and the impact on mortality. We …

Aims B-type natriuretic peptide (BNP) decrease during hospitalization has been related to
reduced risk of readmission and death in patients with acute heart failure (AHF). Conversely …

Differences in the clinical course of congestion by underlying ejection fraction (EF) have not
been well-characterized in acute heart failure (AHF). A post hoc analysis was performed …

Background: Classifying patients with advanced congestive heart failure (CHF) by baseline
measures of congestion and perfusion has been used to estimate hemodynamic status and …